Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
JLABS
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

In the media
JNJ Press releases
Other news
(-) Partner news

Period

2019
2018
2017
2016
2015
2014
2013
2012
2010
2009

Jan
Feb
Mar
(-) Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Locations & regions

Focus area

Clear filters

News

HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing

Read full story

BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-335140

Read full story

Joint Purification Systems, Inc. Announces $7.8 Million Series A Financing

Read full story

ViaCyte Substantially Expands Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications

Read full story

ViaCyte Awarded NIH SBIR Grant to Support In Vitro Development of Stem Cell-Derived Functional Human Pancreatic Beta Cells

Read full story

RefleXion Medical Raises $100 Million Series C to Commercialize Revolutionary Cancer Treatment

Read full story

Aelix Therapeutics appoints HIV expert as CMO

Read full story

Janssen Enters Worldwide Collaboration and License Agreement with TESARO, Inc., for Niraparib in Prostate Cancer

Read full story

Padlock Therapeutics Assembles Scientific Advisory Board with World Leaders in PAD Enzyme Biology and Autoimmune Disease

Read full story

Johnson & Johnson Innovation Commits $15M to Vivo Capital

Read full story

Atlas Completes Final Tranche of £16.9 Million Series B Fundraising

Read full story

Canadian Biotech Industry Recognizes Top Performers

Read full story

Aquinox Pharmaceuticals Completes US $18 Million Series C Financing

Read full story

Synthon acquires LEX System℠ from Biolex Therapeutics

Read full story

Five Prime Therapeutics Announces Second Strategic Alliance with GlaxoSmithKline

Read full story

Load More

Sidebar

Currently trending

Currently trending

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)
Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.
Zebra Medical Vision Announces Agreement With DePuy Synthes to Deploy Cloud Based Artificial Intelligence Orthopaedic Surgical Planning Tools
At the Bio-Europe conference in Hamburg last month, experts weighed in on the challenges and future of neuroscience
The science of prevention
Syndesi Therapeutics announces successful completion of first-in-human Phase I study of novel SV2A modulator, SDI-118, in development for the treatment of cognitive impairment.
Medopad And Janssen Develop Automated Digital Test To Detect Alzheimer’s Earlier
Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute
Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute
Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.

Trending

Trending

Change 1 Thing, Change Everything: Improving Contact Lenses

Change 1 Thing, Change Everything: Improving Hip Replacement

Johnson & Johnson Innovation, Change One Thing, Change Everything: AdoRx